Symbol="KRYS"
AssetType="Common Stock"
Name="Krystal Biotech Inc"
Description="Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United States. The company is headquartered in Pittsburgh, Pennsylvania."
CIK="1711279"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3112734000"
EBITDA="-127884000"
PERatio="None"
PEGRatio="None"
BookValue="18.98"
DividendPerShare="0"
DividendYield="0"
EPS="-5.44"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.143"
ReturnOnEquityTTM="-0.261"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-5.44"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="137.43"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="3.382"
EVToRevenue="-"
EVToEBITDA="-11.46"
Beta="0.806"
num_52WeekHigh="131.8"
num_52WeekLow="61.11"
num_50DayMovingAverage="108.32"
num_200DayMovingAverage="84.65"
SharesOutstanding="25799700"
DividendDate="None"
ExDividendDate="None"
symbol="KRYS"
open="121.27"
high="123.20"
low="120.31"
price="120.65"
volume="179377.00"
latest_trading_day="2023-07-07"
previous_close="121.34"
change="-0.69"
change_percent="-0.5687%"
aroon_positive_momentum_days="84"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="84"
Volume_recent_avg="271871"
Change_recent_avg="0.4"
Delta_recent_avg="3.95"
Variance_recent_avg="1.97"
Change_ratio_recent_avg="0.35"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="84"
Aroon_momentum_negative="16"
image_negative_thumbnail_id_1="1134"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0167.jpeg"
image_negative_thumbnail_id_2="1129"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0162.jpeg"
image_neutral_thumbnail_id_1="589"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_neutral_thumbnail_id_2="570"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_positive_thumbnail_id_1="1006"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0168.jpeg"
image_positive_thumbnail_id_2="675"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0033.jpeg"
image_professor_thumbnail_id_1="1171"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
